Compare API3 (API3) vs Enzyme (MLN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
API3 vs Enzyme — how do they compare? API3 trades at Rp3,989 (market cap Rp343,37M, Rp143,8M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: API3 is far larger — about 2.6× Enzyme's market cap, and API3's circulating supply is 86,4M API3 versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold API3 for 40 Days and Enzyme for 28 Days on average.
| API3 | MLN | |
|---|---|---|
Market Cap | Rp343,37M | Rp134,13M |
Volume (24h) | Rp143,8M | Rp104,56M |
Circulating Supply | 86,4M API3 | 3,3M MLN |
Typical Hold Time | 40 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
API3 is currently trading at Rp3,949 with a bearish technical signal, showing selling pressure across moving averages while oscillators remain neutral. The token faces immediate resistance at Rp4,104 and support at Rp3,942. With a market cap of Rp348.44 million and average hold time of 40 days, the asset shows moderate holding patterns amid current market conditions.
Overall outlook remains cautious with key resistance levels posing challenges for upward movement. Major risks include technical bearish momentum and limited liquidity, while opportunities exist if the token can break above resistance levels. Investors should monitor network adoption and exchange dynamics closely.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About API3
API3 is an ERC-20 token based on the Ethereum blockchain. API3's goal is to allow decentralized versions of APIs to be built, managed, and monetized at scales. To achieve this in a fully decentralized way, the incentives of the participants are reconciled through the governance, security, and value capture utilities of the API3 token. The project has a completely open and direct governance model, where any API3 token holder can stake to obtain direct voting privileges in the API3 DAO.
Read more on API3 →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
